Showing 1,301 - 1,320 results of 1,447 for search '"liver disease"', query time: 0.07s Refine Results
  1. 1301
  2. 1302

    Prediction and Risk Factors for Prognosis of Cirrhotic Patients with Hepatic Encephalopathy by Ying Peng, Qinglin Wei, Yun Liu, Zhenyu Wu, Hongjia Zhang, Hongbo Wu, Jin Chai

    Published 2021-01-01
    “…Acute-on-chronic liver failure (ACLF) mainly occurs in patients with chronic liver diseases and often presents with HE. Several predictive models have been proposed to predict the outcomes of these patients. …”
    Get full text
    Article
  3. 1303

    Resolved Hepatitis B: Achieved or Imaginary Wellbeing? by S. N. Batskikh

    Published 2021-04-01
    “…PHB with chronic liver diseases of various aetiology significantly rises the risk of cirrhosis and hepatic cancer. …”
    Get full text
    Article
  4. 1304
  5. 1305
  6. 1306

    Nuclear receptors in regulation of bile acids transport and metabolism by A. F. Sheptulina, Ye. N. Shirokova, V. T. Ivashkin

    Published 2013-10-01
    “…Accumulation of BA and other bile components in hepatocytes during cholestatic liver diseases is accompanied by liver cells damage and ready to fibrosis and cirrhosis. …”
    Get full text
    Article
  7. 1307
  8. 1308
  9. 1309
  10. 1310

    Akkermansia muciniphila Mediated the Preventive Effect of Disulfiram on Acute Liver Injury via PI3K/Akt Pathway by Ruonan Zhang, Xuewei Sun, Han Lu, Xinrui Zhang, Mingyan Zhang, Xuewen Ji, Xinyi Yu, Chengliang Tang, Zihan Wu, Yinghua Mao, Jin Zhu, Minjun Ji, Zhan Yang

    Published 2025-01-01
    “…The enterohepatic axis is one of the targets of recent attention due to its important role in liver diseases. Disulfiram (DSF) is a multitarget drug that has been proven to play a role in a variety of liver diseases and can affect intestinal flora, but whether it can alleviate ALI is not clear. …”
    Get full text
    Article
  11. 1311

    Mesenchymal stromal cell-derived extracellular vesicles as nanotherapeutics for concanavalin a-induced hepatitis: modulating the gut‒liver axis by Fan Yang, Beibei Ni, Xiaoqi Liang, Yizhan He, Chao Yuan, Jiajie Chu, Yiju Huang, Hongyu Zhong, Li Yang, Jianxi Lu, Yan Xu, Qi Zhang, Wenjie Chen

    Published 2025-01-01
    “…Abstract Background As cell-free nanotherapeutics, extracellular vesicles derived from mesenchymal stem cells (MSC-EVs) have shown potential therapeutic action against liver diseases. However, their effects on autoimmune hepatitis (AIH) are not yet well understood. …”
    Get full text
    Article
  12. 1312
  13. 1313

    Treatment of intractable pruritus in patients with cholestasis with molecular adsorbents recirculating system dialysis: a case series by Magdalena Antoszewska, Piotr Spychalski, Gerda Elisabeth Villadsen, Niels Kristian Muff Aagaard

    Published 2021-09-01
    “…Pruritus commonly occurs in patients with cholestatic liver diseases. Pruritus that is refractory to pharmacological treatment may be an indication for liver transplantation [1–3]. …”
    Get full text
    Article
  14. 1314

    The theses for MD degree by article Editorial

    Published 2011-02-01
    “…Idrisova – Value of a latent HBV-infection in progression of chronic liver diseases.T.A. Batyukhno - Chronic pancreatitis: disorders of protective immune mechanisms and their pharmacological treatment.S.P. …”
    Get full text
    Article
  15. 1315

    Intractable Fasting Hypoglycemia as a Manifestation of Hepatocellular Carcinoma by Justin J. Forde, Ofor Ewelukwa, Tony Brar, Roniel Cabrera

    Published 2017-01-01
    “…Non-islet cell tumor hypoglycemia (NICTH) is a rare and serious paraneoplastic complication of both malignant and benign tumors to consider when evaluating fasting hypoglycemia, especially in the setting of liver diseases. We present a case of NICTH in a 54-year-old male with hepatocellular carcinoma (HCC) who presented with symptomatic intractable hypoglycemia (IH) after bowel preparation and fasting for screening upper endoscopy and colonoscopy.…”
    Get full text
    Article
  16. 1316
  17. 1317

    Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling by Weidong Shao, Hui Xu, Kanghua Zeng, Mingzhou Ye, Renjun Pei, Kai Wang

    Published 2025-01-01
    “…The liver organoids also serve as ideal platforms for studying liver diseases such as hepatitis, liver fibrosis, viral liver diseases, and monogenic diseases. …”
    Get full text
    Article
  18. 1318

    The Effect of an Aqueous Extract of Teucrium polium on Glutathione Homeostasis In Vitro: A Possible Mechanism of Its Hepatoprotectant Action by Stella Shtukmaster, Predrag Ljubuncic, Arieh Bomzon

    Published 2010-01-01
    “…Teucrium polium is used in Arab traditional medicine to treat liver diseases. Glutathione is an important intracellular antioxidant, and intrahepatic glutathione levels are depleted in liver diseases. …”
    Get full text
    Article
  19. 1319
  20. 1320